These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7121122)

  • 41. [Contraceptives and pseudocholinesterase].
    Puente J; García Mora R; Anibarro M; Bernat J; Civera M; Camarasa J; Costa J; Colomer MJ; Payá A; Puerto E
    Rev Esp Anestesiol Reanim; 1975 Sep; 22(5):433-8. PubMed ID: 1188141
    [No Abstract]   [Full Text] [Related]  

  • 42. [Levels of plasma pseudocholinesterase in chronic renal insufficiency patients and hemodialysis].
    Vila P; Silla I; Porta J; Fontestad A; Montero Benzo R
    Rev Esp Anestesiol Reanim; 1987; 34(6):431-7. PubMed ID: 3423372
    [No Abstract]   [Full Text] [Related]  

  • 43. [Serum levels of pseudocholinesterase in alcoholic cirrhosis patients. Correlation with the extent of anatomo-functional damage. Unfavorable prognostic index].
    Sportiello V; Pace M; Fernandes D; Stefan C
    Arch Sci Med (Torino); 1981; 138(3):307-13. PubMed ID: 7316740
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis.
    Burns JL; Van Dalfsen JM; Shawar RM; Otto KL; Garber RL; Quan JM; Montgomery AB; Albers GM; Ramsey BW; Smith AL
    J Infect Dis; 1999 May; 179(5):1190-6. PubMed ID: 10191222
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M; Tempero K; Kirby M; Thompson J
    Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Persistence of typable activity of pseudocholinesterase (E2 locus) -C5 component polymorphism in human bloodstains under Indian climatic conditions.
    Joshi H; Sivaram S; Dua RD
    Indian J Exp Biol; 1979 Mar; 17(3):258-61. PubMed ID: 468329
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of a single dose of tobramycin on systemic inflammatory response-induced acute kidney injury in a 6-hour porcine model.
    Lipcsey M; Carlsson M; Larsson A; Algotsson L; Eriksson M; Lukinius A; Sjölin J
    Crit Care Med; 2009 Oct; 37(10):2782-90. PubMed ID: 19707126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Behavior of pseudocholinesterase serum level in patients treated for a long time with Trasylol].
    Marcello B
    Acta Anaesthesiol; 1969; 20(3):455-67. PubMed ID: 4253898
    [No Abstract]   [Full Text] [Related]  

  • 49. Studies on the metabolism of benoxinate by human pseudocholinesterase.
    Dubbels R; Schloot W
    Metab Pediatr Syst Ophthalmol; 1983; 7(1):37-43. PubMed ID: 6621359
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of ofloxacin, pefloxacin, and tobramycin on the hydrophobicity of Klebsiella pneumoniae].
    Hostacká A
    Epidemiol Mikrobiol Imunol; 1999 Feb; 48(1):28-30. PubMed ID: 11038674
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tobramycin penetration into epithelial lining fluid of patients with pneumonia.
    Carcas AJ; García-Satué JL; Zapater P; Frías-Iniesta J
    Clin Pharmacol Ther; 1999 Mar; 65(3):245-50. PubMed ID: 10096256
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Determination of atypical pseudocholinesterase].
    Schopp-Pintea K; Cardan E; Jebeleanu G; Abrudan M
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(4):315-8. PubMed ID: 2931764
    [No Abstract]   [Full Text] [Related]  

  • 53. [Case of silent type pseudocholinesterasemia].
    Ishikawa Y; Aizawa Y; Izumi T; Shibata A
    Nihon Naika Gakkai Zasshi; 1982 Sep; 71(9):1289-93. PubMed ID: 7153631
    [No Abstract]   [Full Text] [Related]  

  • 54. Tobramycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 1997 Oct; 62(4):392-9. PubMed ID: 9357390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Succinylcholine and low serum pseudocholinesterase activity - effect of administration of purified human pseudocholinesterase].
    Yamamoto E; Iwai Y; Takagi T; Tsuda E; Muteki G
    Masui; 1975 Oct; 24(10):1006-11. PubMed ID: 1239519
    [No Abstract]   [Full Text] [Related]  

  • 56. True and pseudo cholinesterases in depression.
    Mathew RJ; Ho BT; Khan MM; Perales C; Weinman ML; Claghorn JL
    Am J Psychiatry; 1982 Jan; 139(1):125-7. PubMed ID: 7055257
    [No Abstract]   [Full Text] [Related]  

  • 57. [Aminoglycosides and colistin inhibit biofilm formation in Klebsiella pneumoniae].
    Hostacká A; Ciznár I
    Epidemiol Mikrobiol Imunol; 2008 Aug; 57(3):101-5. PubMed ID: 18767377
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Pseudocholinesterase in patients with and without liver diseases (author's transl)].
    Gentz HD; Schlicht I; Wiederholt W
    Med Klin; 1978 Oct; 73(41):1422-6. PubMed ID: 703668
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety.
    Geller DE; Konstan MW; Smith J; Noonberg SB; Conrad C
    Pediatr Pulmonol; 2007 Apr; 42(4):307-13. PubMed ID: 17352404
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparative study of LDH & PchE in sera of cancer patients; a preliminary report.
    Ghooi AM; Malaviya GN; Kashyap A
    Indian J Cancer; 1980 Mar; 17(1):31-3. PubMed ID: 7399552
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.